Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2026
Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection
Luis H Cisneros, Merih D Toruner, Zafar Siddiqui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2025
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma
Parul Agarwal, Matthew Guo, Kabeer Munjal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 12, 2026
Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs
Sarah O Osman, Alex Dunlop, Sophie Alexander, et al.
JAMA Surgery
|
March 18, 2026
AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma
Sam Z Thalji, Mohammed Aldakkak, Adhitya Ramamurthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Open-label, Phase I Study of Nivolumab Combined with <i>nab</i>-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer
Zev A Wainberg, Howard S Hochster, Edward J Kim, et al.
Gastroenterology
|
January 27, 2024
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma
Ben George, Olga Kudryashova, Andrey Kravets, et al.
Cancer Research
|
October 24, 2025
Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, G Aaron Hobbs, Raven Davidson, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer
Komal Sharma, Divin A Wilson, Yu Wang, et al.
Journal for Immunotherapy of Cancer
|
January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2026
Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection
Luis H Cisneros, Merih D Toruner, Zafar Siddiqui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2025
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma
Parul Agarwal, Matthew Guo, Kabeer Munjal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 12, 2026
Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs
Sarah O Osman, Alex Dunlop, Sophie Alexander, et al.
JAMA Surgery
|
March 18, 2026
AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma
Sam Z Thalji, Mohammed Aldakkak, Adhitya Ramamurthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Open-label, Phase I Study of Nivolumab Combined with <i>nab</i>-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer
Zev A Wainberg, Howard S Hochster, Edward J Kim, et al.
Gastroenterology
|
January 27, 2024
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma
Ben George, Olga Kudryashova, Andrey Kravets, et al.
Cancer Research
|
October 24, 2025
Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, G Aaron Hobbs, Raven Davidson, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer
Komal Sharma, Divin A Wilson, Yu Wang, et al.
Journal for Immunotherapy of Cancer
|
January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, et al.
Page
of 13